tradingkey.logo
tradingkey.logo
Search

BioXcel Therapeutics Inc

BTAI
Add to Watchlist
0.808USD
+0.015+1.92%
Close 07-31 16:00ETQuotes delayed by 15 min
24.95MMarket Cap
LossP/E TTM

BTAI Cash Flow Statement

You can access the annual and quarterly cash flow statements of BioXcel Therapeutics Inc to evaluate its financial soundness and stability.
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
FY2021Q1
FY2020Q4
FY2020Q3
FY2020Q2
FY2020Q1
FY2019Q4
FY2019Q3
FY2019Q2
FY2019Q1
FY2018Q4
FY2018Q3
FY2018Q2
FY2018Q1
FY2017Q4
FY2017Q3
FY2017Q1
FY2016Q4
FY2016Q3
Operating cash flows (indirect method)
Cash flow from continuing operating activities
1.94%-11.81M
4.04%-14.21M
-14.99%-18.79M
45.74%-12.57M
31.98%-12.04M
44.87%-14.81M
56.53%-16.34M
39.34%-23.17M
66.18%-17.71M
30.48%-26.86M
-20.52%-37.58M
-15.42%-38.21M
-61.52%-52.35M
-93.85%-38.64M
-54.39%-31.19M
-47.90%-33.10M
-65.04%-32.41M
1.68%-19.93M
-5.75%-20.20M
-51.03%-22.38M
-61.55%-19.64M
-155.99%-20.27M
-155.19%-19.10M
-145.89%-14.82M
-114.41%-12.16M
-82.42%-7.92M
-134.93%-7.49M
-21.27%-6.03M
-460.28%-5.67M
-295.36%-4.34M
-889.44%-3.19M
---4.97M
-134.80%-1.01M
-239.94%-1.10M
5.01%-322.00K
---431.00K
---323.00K
---339.00K
Net income from continuing operations
-74.95%-12.69M
-15.53%-12.54M
-126.45%-30.91M
-131.20%-19.19M
72.92%-7.25M
51.21%-10.86M
72.96%-13.65M
84.49%-8.30M
49.26%-26.79M
59.39%-22.26M
-20.76%-50.49M
-42.06%-53.52M
-67.76%-52.80M
-109.79%-54.81M
-55.93%-41.81M
-36.39%-37.67M
-19.32%-31.47M
-23.90%-26.13M
-8.31%-26.81M
-28.95%-27.62M
-76.89%-26.38M
-154.82%-21.09M
-174.48%-24.75M
-152.85%-21.42M
-106.98%-14.91M
-16.96%-8.28M
-84.53%-9.02M
-179.94%-8.47M
-68.24%-7.20M
-179.87%-7.08M
-432.93%-4.89M
---3.03M
-709.45%-4.28M
-350.62%-2.53M
-69.19%-917.00K
---529.00K
---561.00K
---542.00K
Operating gains losses
-23.68%58.00K
-3.90%74.00K
-2.60%75.00K
-2.60%75.00K
-2.56%76.00K
-1.28%77.00K
-2.53%77.00K
-4.94%77.00K
-2.50%78.00K
-3.70%78.00K
-7.06%79.00K
-3.57%81.00K
3.90%80.00K
6.58%81.00K
10.39%85.00K
6.33%84.00K
18.46%77.00K
68.89%76.00K
60.42%77.00K
64.58%79.00K
38.30%65.00K
--45.00K
-50.00%48.00K
-43.53%48.00K
27.03%47.00K
----
1271.43%96.00K
4150.00%85.00K
--37.00K
--8.00K
600.00%7.00K
--2.00K
-100.00%0.00
--0.00
--1.00K
--1.00K
----
----
Other non-cash items
43.43%502.00K
111.26%469.00K
315.09%440.00K
309.38%393.00K
713.95%350.00K
-27.69%222.00K
-71.88%106.00K
-73.03%96.00K
-87.09%43.00K
-4.66%307.00K
73.73%377.00K
10.90%356.00K
--333.00K
--322.00K
--217.00K
--321.00K
----
----
----
----
----
----
----
----
-100.00%0.00
---62.00K
----
---500.00K
--500.00K
----
----
----
----
----
----
----
----
----
Change in working capital
193.48%1.41M
75.72%-844.00K
-21.51%-1.51M
146.50%2.49M
-134.61%-1.50M
61.91%-3.48M
-115.54%-1.25M
-160.14%-5.35M
179.35%4.34M
-188.25%-9.13M
45.91%8.02M
2877.81%8.89M
-13.07%-5.48M
166.45%10.34M
242.64%5.50M
80.14%-320.00K
-537.88%-4.84M
166.43%3.88M
377.38%1.60M
-135.06%-1.61M
-42.72%1.11M
-2375.42%-5.84M
-49.17%336.00K
151.23%4.59M
513.02%1.93M
-109.10%-236.00K
-17.89%661.00K
168.07%1.83M
-83.85%315.00K
662.65%2.59M
189.57%805.00K
---2.69M
19610.00%1.95M
439.68%340.00K
1363.16%278.00K
---10.00K
--63.00K
--19.00K
-Change in receivables
-87.02%17.00K
-82.03%-233.00K
-97.90%17.00K
96.08%-17.00K
142.67%131.00K
-119.28%-128.00K
366.12%809.00K
-193.24%-434.00K
-777.14%-307.00K
367.74%664.00K
---304.00K
---148.00K
---35.00K
---248.00K
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
-Change in inventory
500.00%222.00K
-131.09%-263.00K
-95.93%47.00K
156.43%136.00K
108.26%37.00K
3033.33%846.00K
1341.94%1.16M
-992.59%-241.00K
-1457.58%-448.00K
104.68%27.00K
-615.38%-93.00K
103.79%27.00K
104.84%33.00K
---577.00K
---13.00K
---713.00K
---682.00K
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
-Change in prepaid expenses
-270.89%-1.04M
-876.49%-8.35M
67.10%-480.00K
114.16%65.00K
-32.52%608.00K
-173.45%-855.00K
-164.82%-1.46M
-131.03%-459.00K
144.92%901.00K
13.12%1.16M
5.29%2.25M
141.17%1.48M
42.36%-2.01M
-44.14%1.03M
416.74%2.14M
-103.28%-3.59M
-595.02%-3.48M
257.84%1.84M
-331.96%-675.00K
-352.07%-1.77M
138.25%703.00K
-104.02%-1.17M
-25.58%291.00K
147.70%701.00K
-42.26%-1.84M
-2283.33%-572.00K
158.94%391.00K
103.60%283.00K
-60.50%-1.29M
-400.00%-24.00K
1472.73%151.00K
--139.00K
-80600.00%-805.00K
60.00%8.00K
-466.67%-11.00K
--1.00K
--5.00K
--3.00K
-Change in payables and accrued expense
197.62%2.21M
340.60%8.01M
34.74%-1.08M
155.60%2.31M
-147.02%-2.27M
72.96%-3.33M
-122.89%-1.66M
-164.06%-4.16M
203.70%4.83M
-233.37%-12.32M
1411.46%7.25M
62.79%6.50M
-588.46%-4.65M
352.03%9.23M
-78.65%480.00K
2458.33%3.99M
-267.74%-676.00K
143.70%2.04M
4895.56%2.25M
-95.99%156.00K
-89.31%403.00K
-1491.37%-4.67M
-83.33%45.00K
151.23%3.89M
135.12%3.77M
-87.16%336.00K
-58.72%270.00K
155.10%1.55M
-41.56%1.60M
688.25%2.62M
126.30%654.00K
---2.81M
25036.36%2.74M
472.41%332.00K
1706.25%289.00K
---11.00K
--58.00K
--16.00K
-Change in other current assets
-29.11%56.00K
6.33%84.00K
6.49%82.00K
8.00%81.00K
5.33%79.00K
6.76%79.00K
6.94%77.00K
4.17%75.00K
7.14%75.00K
7.25%74.00K
4.35%72.00K
7.46%72.00K
6.06%70.00K
6.15%69.00K
-65.33%69.00K
--67.00K
--66.00K
--65.00K
--199.00K
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
Cash from non-recurring investing activities
Cash from operating activities
1.94%-11.81M
4.04%-14.21M
-14.99%-18.79M
45.74%-12.57M
31.98%-12.04M
44.87%-14.81M
56.53%-16.34M
39.34%-23.17M
66.18%-17.71M
30.48%-26.86M
-20.52%-37.58M
-15.42%-38.21M
-61.52%-52.35M
-93.85%-38.64M
-54.39%-31.19M
-47.90%-33.10M
-65.04%-32.41M
1.68%-19.93M
-5.75%-20.20M
-51.03%-22.38M
-61.55%-19.64M
-155.99%-20.27M
-155.19%-19.10M
-145.89%-14.82M
-114.41%-12.16M
-82.42%-7.92M
-134.93%-7.49M
-21.27%-6.03M
-460.28%-5.67M
-295.36%-4.34M
-889.44%-3.19M
---4.97M
-134.80%-1.01M
-239.94%-1.10M
5.01%-322.00K
---431.00K
---323.00K
---339.00K
Investing cash flow
Net cash from continuing investing activities
--0.00
--0.00
--0.00
----
--0.00
----
----
----
----
--0.00
--0.00
5.26%20.00K
-100.00%0.00
-100.00%0.00
-100.00%0.00
-81.00%19.00K
-62.03%120.00K
-95.56%12.00K
440.00%17.00K
185.71%100.00K
1875.00%316.00K
13400.00%270.00K
-111.63%-5.00K
-84.44%35.00K
-97.33%16.00K
-98.73%2.00K
-30.65%43.00K
87.50%225.00K
--600.00K
--158.00K
--62.00K
--120.00K
----
-100.00%0.00
-100.00%0.00
----
--3.00K
--1.00K
Capital expenditures
--0.00
--0.00
--0.00
----
--0.00
----
----
----
----
--0.00
--0.00
5.26%20.00K
-100.00%0.00
-100.00%0.00
-100.00%0.00
-81.00%19.00K
-62.03%120.00K
-95.56%12.00K
--17.00K
185.71%100.00K
1875.00%316.00K
13400.00%270.00K
----
-84.44%35.00K
-97.33%16.00K
-98.73%2.00K
-30.65%43.00K
87.50%225.00K
--600.00K
--158.00K
--62.00K
--120.00K
----
-100.00%0.00
-100.00%0.00
----
--3.00K
--1.00K
Net cash flow from disposal of fixed assets
--0.00
--0.00
--0.00
----
--0.00
----
----
----
----
--0.00
--0.00
5.26%20.00K
-100.00%0.00
-100.00%0.00
-100.00%0.00
-81.00%19.00K
-62.03%120.00K
-95.56%12.00K
440.00%17.00K
185.71%100.00K
1875.00%316.00K
13400.00%270.00K
-111.63%-5.00K
-84.44%35.00K
-97.33%16.00K
-98.73%2.00K
-30.65%43.00K
87.50%225.00K
--600.00K
--158.00K
--62.00K
--120.00K
----
-100.00%0.00
-100.00%0.00
----
--3.00K
--1.00K
Net cash flow from other investing activities
--0.00
--0.00
--0.00
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
Cash from non-current investing activities
Net cash flow from investing activities
--0.00
--0.00
--0.00
--0.00
--0.00
----
--0.00
----
----
--0.00
--0.00
-5.26%-20.00K
100.00%0.00
100.00%0.00
100.00%0.00
81.00%-19.00K
62.03%-120.00K
95.56%-12.00K
-440.00%-17.00K
-185.71%-100.00K
-1875.00%-316.00K
-13400.00%-270.00K
111.63%5.00K
84.44%-35.00K
97.33%-16.00K
98.73%-2.00K
30.65%-43.00K
-87.50%-225.00K
---600.00K
---158.00K
---62.00K
---120.00K
----
100.00%0.00
100.00%0.00
----
---3.00K
---1.00K
Financing cash flow
Cash flow from continuous financing activities
-98.24%232.00K
32.06%5.65M
8166.96%37.53M
-97.42%137.00K
-50.42%13.20M
101.41%4.28M
--454.00K
2021.60%5.30M
10.26%26.63M
4146.00%2.12M
-100.00%0.00
-99.62%250.00K
--24.15M
--50.00K
42221.13%30.05M
-34.85%66.14M
-100.00%0.00
-100.00%0.00
-99.96%71.00K
37362.73%101.52M
-98.58%852.00K
145.26%233.00K
949.84%187.03M
443.04%271.00K
5982500.00%59.83M
263.79%95.00K
84733.33%17.82M
-203.85%-79.00K
-100.00%1.00K
-104.71%-58.00K
-97.35%21.00K
---26.00K
12797.91%55.59M
277.61%1.23M
132.65%791.00K
--431.00K
--326.00K
--340.00K
Net cash flow from debt Issuance/repayment
---8.11M
100.00%0.00
----
----
----
---2.50M
----
----
----
----
-100.00%0.00
----
----
--0.00
--30.00M
--68.60M
----
----
----
----
----
----
----
----
----
----
----
--0.00
100.00%0.00
----
-100.00%0.00
--0.00
---371.00K
--2.00K
--84.00K
--0.00
--0.00
--0.00
Net cash flow from common stock issuance/repurchase
-39.33%8.50M
-17.70%5.76M
8069.66%38.23M
-97.44%140.00K
-47.63%14.01M
194.78%7.00M
--468.00K
--5.48M
8.46%26.74M
--2.38M
--0.00
--0.00
--24.66M
--0.00
100.00%0.00
----
----
100.00%0.00
-100.02%-34.00K
--101.03M
-100.00%0.00
-145.95%-34.00K
968.25%187.01M
-100.00%0.00
--59.79M
7300.00%74.00K
--17.51M
--230.00K
-100.00%0.00
-99.92%1.00K
-100.00%0.00
--0.00
--56.51M
--1.31M
--751.00K
--0.00
----
----
Proceeds from stock option exercised by employees
----
----
----
----
----
----
----
----
----
-100.00%0.00
-100.00%0.00
35.14%250.00K
--258.00K
--50.00K
-54.29%48.00K
-62.78%185.00K
-100.00%0.00
-100.00%0.00
400.00%105.00K
83.39%497.00K
2084.62%852.00K
1171.43%267.00K
--21.00K
--271.00K
3800.00%39.00K
200.00%21.00K
--0.00
--0.00
--1.00K
--7.00K
----
----
----
----
----
----
----
----
Net cash flow from other financing activities
80.35%-158.00K
48.89%-115.00K
-4914.29%-702.00K
98.26%-3.00K
-587.18%-804.00K
10.71%-225.00K
---14.00K
---172.00K
84.73%-117.00K
---252.00K
--0.00
100.00%0.00
---766.00K
--0.00
--0.00
---2.65M
----
----
----
----
----
----
----
----
----
----
1371.43%309.00K
-1088.46%-309.00K
100.00%0.00
18.52%-66.00K
147.73%21.00K
---26.00K
-227.84%-551.00K
-124.85%-81.00K
-112.94%-44.00K
--431.00K
--326.00K
--340.00K
Net cash from non-recurrent financing activities
Net cash from financing activities
-98.24%232.00K
32.06%5.65M
8166.96%37.53M
-97.42%137.00K
-50.42%13.20M
101.41%4.28M
--454.00K
2021.60%5.30M
10.26%26.63M
4146.00%2.12M
-100.00%0.00
-99.62%250.00K
--24.15M
--50.00K
42221.13%30.05M
-34.85%66.14M
-100.00%0.00
-100.00%0.00
-99.96%71.00K
37362.73%101.52M
-98.58%852.00K
145.26%233.00K
949.84%187.03M
443.04%271.00K
5982500.00%59.83M
263.79%95.00K
84733.33%17.82M
-203.85%-79.00K
-100.00%1.00K
-104.71%-58.00K
-97.35%21.00K
---26.00K
12797.91%55.59M
277.61%1.23M
132.65%791.00K
--431.00K
--326.00K
--340.00K
Net cash flow
Beginning cash balance
-3.67%28.76M
-7.59%37.32M
-66.99%18.57M
-58.17%31.01M
-54.23%29.85M
-55.11%40.39M
-55.88%56.27M
-55.21%74.14M
-66.33%65.22M
-61.28%89.96M
-45.37%127.55M
-17.42%165.52M
-16.84%193.72M
-8.14%232.31M
-14.50%233.45M
3.31%200.44M
9.31%232.97M
8.35%252.91M
316.91%273.06M
142.28%194.01M
557.25%213.12M
479.92%233.43M
118.57%65.50M
120.63%80.08M
-23.82%32.43M
-14.58%40.25M
-40.49%29.96M
-34.56%36.30M
4698.76%42.56M
6149.60%47.12M
17566.32%50.35M
--55.47M
--887.00K
--754.00K
--285.00K
--0.00
--0.00
--0.00
Current period cash flow changes
-1098.88%-11.58M
18.70%-8.56M
218.01%18.75M
30.40%-12.44M
-87.01%1.16M
57.43%-10.53M
57.74%-15.88M
52.94%-17.87M
131.63%8.92M
35.89%-24.74M
-3202.64%-37.58M
-215.02%-37.98M
13.31%-28.20M
-93.49%-38.59M
94.35%-1.14M
-58.23%33.02M
-70.29%-32.53M
1.80%-19.94M
-112.00%-20.14M
641.98%79.04M
-140.09%-19.10M
-159.51%-20.31M
1532.48%167.93M
-130.36%-14.58M
860.14%47.65M
-71.74%-7.83M
418.78%10.29M
-23.75%-6.33M
-111.49%-6.27M
-3526.32%-4.56M
-788.06%-3.23M
---5.12M
--54.58M
--133.00K
--469.00K
--0.00
--0.00
--0.00
Ending cash balance
-44.60%17.18M
-3.67%28.76M
-7.59%37.32M
-66.99%18.57M
-58.17%31.01M
-54.23%29.85M
-55.11%40.39M
-55.88%56.27M
-55.21%74.14M
-66.33%65.22M
-61.28%89.96M
-45.37%127.55M
-17.42%165.52M
-16.84%193.72M
-8.14%232.31M
-14.50%233.45M
3.31%200.44M
9.31%232.97M
8.35%252.91M
316.91%273.06M
142.28%194.01M
557.25%213.12M
479.92%233.43M
118.57%65.50M
120.63%80.08M
-23.82%32.43M
-14.58%40.25M
-40.49%29.96M
-34.56%36.30M
4698.76%42.56M
6149.60%47.12M
--50.35M
--55.47M
--887.00K
--754.00K
--0.00
--0.00
--0.00
Free cash flow
1.94%-11.81M
---14.21M
---18.79M
----
---12.04M
----
----
----
----
30.48%-26.86M
-20.52%-37.58M
-15.41%-38.23M
-60.92%-52.35M
-93.74%-38.64M
-54.26%-31.19M
-47.33%-33.12M
-63.02%-32.53M
2.91%-19.94M
-5.84%-20.22M
-51.34%-22.48M
-63.94%-19.96M
-159.34%-20.54M
-153.73%-19.10M
-137.60%-14.86M
-94.15%-12.17M
-76.06%-7.92M
-131.77%-7.53M
-22.83%-6.25M
---6.27M
-309.74%-4.50M
-908.70%-3.25M
---5.09M
----
-236.81%-1.10M
5.29%-322.00K
----
---326.00K
---340.00K
Currency unit
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
Audit opinions
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----

FAQs

What is operating cash flow?

Operating cash flow is the cash generated or used by a company's core business operations. It adjusts net income for non-cash items and working capital changes, such as depreciation, receivables, inventory, and payables. Strong operating cash flow can indicate that the business is converting sales and earnings into real cash.

How Much Operating Cash Flow Did BioXcel Therapeutics Inc Generate?

BioXcel Therapeutics Inc generated -57.62M in operating cash flow in fiscal 2025, reflecting cash generated from its core business operations.

How Did BioXcel Therapeutics Inc's Operating Cash Flow Change Year Over Year?

BioXcel Therapeutics Inc's operating cash flow increased by 20.01% year over year.

What is investing cash flow?

Investing cash flow shows cash used for or generated from investment-related activities, such as capital expenditures, purchases or sales of investments, acquisitions, and asset disposals. Negative investing cash flow is not always bad, because it can reflect spending on future growth, but investors should check whether those investments support long-term returns.

What is financing cash flow?

Financing cash flow shows how a company raises capital or returns capital to investors and creditors. It can include debt issuance, debt repayment, share issuance, share repurchases, dividend payments, and lease financing. Positive financing cash flow may show new capital raised, while negative financing cash flow may reflect debt repayment, dividends, or buybacks.

How Has BioXcel Therapeutics Inc's Financing Cash Flow Changed?

BioXcel Therapeutics Inc used 56.52M in financing activities in the latest quarter.

What is free cash flow and why does it matter for BTAI?

Free cash flow is the cash a company has left after funding the capital spending needed to maintain or grow the business. It is often used to assess financial flexibility, debt repayment capacity, dividend sustainability, buyback potential, and valuation quality. Investors should compare free cash flow with net income, revenue growth, and capital expenditures.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.